Received Jul 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 25G23D | — |
KINRIX was administered to a 2 month old child; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-week-old male patient who received DTPa-IPV (Kinrix) (batch number 25G23D, expiry date 21-AUG-2026) for prophylaxis. On 07-JUL-2025, the patient received Kinrix. On 07-JUL-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: KINRIX was administered to a 2 month old child). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-JUL-2025 The heath care professional reported that a dose of Kinrix was administered to a 2 month old child (inappropriate age), which led to inappropriate age at vaccine administration.